Stay updated on Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Sign up to get notified when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2FoguxMA2TnYjm4IZ6HKR4fihCTDw.uncropped.jpg&w=3840&q=75)
Latest updates to the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page
- CheckyesterdayNo Change Detected
- Check2 days agoNo Change Detected
- Check3 days agoNo Change Detected
- Check4 days agoChange DetectedThe study has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check5 days agoNo Change Detected
- Check11 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check25 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent change in the version of the content on the webpage.SummaryDifference0.1%
- Check30 days agoChange DetectedThe value of Revision has been updated from v2.9.3 to v2.9.5, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check31 days agoChange DetectedThe value of Revision has been updated from v2.9.1 to v2.9.3, indicating a recent change in the webpage content.SummaryDifference0.1%
- Check32 days agoChange DetectedThe value 'Show more' has been updated to 'Show less'. Additionally, the content related to MedlinePlus Genetics, MedlinePlus topics, and Genetic and Rare Diseases Information Center resources has been expanded to include information on Melanoma, Neuroendocrine Tumor, Neuroepithelioma, and Drug Information for Ipilimumab and Pembrolizumab.SummaryDifference19%
Stay in the know with updates to Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Low Dose Ipilimumab With Pembrolizumab in Brain Metastases Clinical Trial page.